EV/EBITDA:
-3.53+0.28(+7.35%)Summary
- As of today (June 17, 2025), MLYS EV/EBITDA is -3.53, with a rise of +0.28 (+7.35%) during the most recent trading session on June 16, 2025.
- Over the past year, MLYS EV/EBITDA has increased by +1.37 (+27.96%).
- MLYS EV/EBITDA is now -116.56% below its all-time high of -1.63.
Performance
MLYS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLYS EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +7.3% | -7.4% | -6.1% |
1 m1 month | +14.9% | -14.8% | -12.4% |
3 m3 months | +14.7% | -10.7% | -5.4% |
6 m6 months | -15.0% | +37.5% | +8.9% |
ytdytd | -35.8% | +42.5% | +9.3% |
1 y1 year | +28.0% | +38.1% | +10.3% |
5 y5 years | - | - | - |
MLYS EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -3.53 | at high | -4.57 | +22.8% |
3 m | 3-month | -2.97 | -18.9% | -5.08 | +30.5% |
6 m | 6-month | -1.63 | -116.6% | -5.08 | +30.5% |
1 y | 1-year | -1.63 | -116.6% | -5.11 | +30.9% |
3 y | 3-year | -1.63 | -116.6% | -22.06 | +84.0% |
5 y | 5-year | -1.63 | -116.6% | -22.06 | +84.0% |
alltime | all time | -1.63 | -116.6% | -22.06 | +84.0% |
MLYS EV/EBITDA History
Date | Value |
---|---|
2025 | -3.53(+35.8%) |
Date | Value |
---|---|
2024 | -2.60(-27.8%) |
2023 | -3.60 |
FAQ
- What is Mineralys Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Mineralys Therapeutics?
- What is MLYS EV/EBITDA year-to-date change?
- What is Mineralys Therapeutics EV/EBITDA year-on-year change?
What is Mineralys Therapeutics EV/EBITDA?
The current EV/EBITDA of MLYS is -3.53
What is the all time high EV/EBITDA for Mineralys Therapeutics?
Mineralys Therapeutics all-time high EV/EBITDA is -1.63
What is MLYS EV/EBITDA year-to-date change?
Mineralys Therapeutics EV/EBITDA has changed by -0.93 (-35.77%) since the beginning of the year
What is Mineralys Therapeutics EV/EBITDA year-on-year change?
Over the past year, MLYS EV/EBITDA has changed by +1.37 (+27.96%)